Jazz Pharmaceuticals plc: chief commercial officer to retire by Jun 30, 2027

What happened Jazz Pharmaceuticals plc filed an 8-K reporting that on Oct 6, 2026, Samantha Pearce notified the company of her intent to retire from her role as Executive Vice President, Chief Commercial Officer, upon the earlier of the selection and appointment of her successor or by Jun 30, 2027.

Key details

• Notice date: Oct 6, 2026.
• Named executive: Samantha Pearce, Executive Vice President, Chief Commercial Officer.
• Retirement effective: upon selection and appointment of her successor or by Jun 30, 2027.
• The company plans to commence a formal search that will consider internal and external candidates.

Why it may matter This report was filed under Item 5.02 (departure of directors or certain officers), which covers notices of resignation or retirement and related succession arrangements. The filing does not show why the insider traded or why the company acted.